Analyst upgrades: SNY, LIFC, MYL, PNRA and NHY
Posted Oct 4th 2007 10:45AM by Eric Buscemi
Filed under: Analyst Reports, Analyst Upgrades and Downgrades, Ciena Corp (CIEN), Rite Aid Corp (RAD)
.gif)
MOST NOTEWORTHY: Sanofi-Aventis, Lifecell, Mylan Labs, Panera Bread and Norsk Hydro were today's noteworthy upgrades:
- Societe Generale upgraded shares of Sanofi-Aventis (NYSE: SNY) to Buy from Hold as they believe pipeline maturation over the next 12 months can drive the stock higher.
- Piper upgraded shares of Lifecell (NASDAQ: LIFC) to Outperform from Market Perform after their recent survey indicated that AlloDerm remains the leading biologic hernia mesh on the market and competition is making little headway.
- JP Morgan upgraded Mylan Labs (NYSE: MYL), Panera Bread (NASDAQ: PNRA) and Norsk Hydro (NYSE: NHY) to Overweight from Neutral. The firm upgraded Mylan based on its position in the global generics market and above-average growth; Panera was upgraded on valuation, as they believe the recent operating risk is now behind the company; Norsk Hydro was upgraded, as they believe the value of the company's aluminum assets are higher than the current share price suggests.
OTHER UPGRADES:
Tags: analyst, cien, ciena, cyt, cytec, lifc, lifecell, myl, mylan, nhy, norsk hydro, NorskHydro, panera, pnra, rad, rite aid, RiteAid, sanofi-aventis, sny, spf, standard pacific, StandardPacific, upgrade
Tax Reform in This Election Year: It's Not Likely
Which Credit Card Rewards Does the IRS Care About?
Goldman Earnings Sink After Buffett Dividend
Johnson & Johnson's Income Falls 23%
Burberry Shares Leap on Sales Update
